News

Seasats Deploys Lightfish USV Fleet to Gulf of America Border Mission

San Diego – October 02, 2026 -- Seasats has deployed a fleet of Lightfish unmanned surface vessels into the Gulf of America for persistent maritime border surveillance, expanding a federal autonomous maritime program run under the Office of the Assistant Secretary of War for Homeland Defense and Americas Security Affairs.

Lightfish fleet launches from Texas coast into Gulf waters

Launched from the Texas coast, the autonomous fleet will conduct continuous surveillance to detect drug trafficking and unauthorized vessel incursions in the Gulf, building on the company's prior support of Operation River Wall along the southern border.

Roland Foods to Acquire Savor Brands From Dot Foods in Equity Tie-Up

New York – October 02, 2026 -- Roland Foods, LLC will acquire Savor Brands, LLC from Dot Foods, Inc. under a strategic partnership that also gives Dot Foods an equity interest in Roland Foods, the companies announced. The deal pairs Roland Foods' 2,400-product global ingredient portfolio with Savor's frozen offerings and expanded import range, while Dot Foods will distribute both Roland and Savor products through its nationwide less-than-truckload redistribution network.

Dot Foods gains equity stake while keeping distribution role

Dot Foods, which carries 130,000 products from 1,500 manufacturers and operates 13 U.S. distribution centers plus two in Canada, will become both a shareholder in Roland Foods and its commercial distribution partner. Keith Dougherty, CEO of Roland Foods, said the Dot relationship will make it easier for customers to buy from the combined business.

Rareview Capital Launches BCOM ETF Tracking Bloomberg Commodity Index

Las Vegas – October 02, 2026 -- Rareview Capital LLC has launched the Rareview Bloomberg Commodity Index ETF, trading under the symbol BCOM, offering passive exposure to the Bloomberg Commodity Index Total Return.

Fund tracks 24 futures contracts across 22 commodities as of April 30, 2026

The ETF is weighted two-thirds by trading volume or liquidity and one-third by world production or global economic significance. Weight caps limit any single commodity to 15% and any sector to 33%, capping concentration risk across energy, metals, agriculture and livestock.

AKASA Launches Autonomous AI Coding Covering 10% of U.S. Discharges

South San Francisco, Calif. – October 02, 2026 -- AKASA has launched an autonomous AI platform for inpatient medical coding and clinical documentation integrity (CDI), expanding beyond its existing prebill review tools after inpatient volume processed by the company grew nearly 6x over the past year.

AKASA's health system customers now cover 10% of U.S. inpatient discharges

The company's customer base collectively represents more than $180 billion in aggregate net patient revenue and roughly 10% of all U.S. inpatient discharges. The growth has been driven by adoption of AKASA's existing AI-powered prebill review products, which the company says created the volume and performance data needed to move into fully autonomous coding.

Gunvor Rebrands as Centalion, Plans Singapore Redomicile

Geneva – October 02, 2026 -- The employee partnership owning Gunvor Group Ltd has voted to rename the company Centalion Group Ltd and relocate its corporate headquarters from Cyprus to Singapore, marking the next phase after a December 2025 management buyout.

Partnership referendum backs new brand after six-month review

The name change followed a full partnership referendum in July 2026, preceded by six months of employee engagement and market-positioning research conducted by brand specialist Landor. Gary Pedersen, Chairman and CEO of Centalion, said the move reflects "one team, moving together, at the heart of the global energy markets," framing it as a step taken from a position of commercial strength rather than necessity.

Quotient Sciences, Acesion Pharma Partner on AI Drug Formulation

Nottingham, England – October 02, 2026 -- Quotient Sciences and Copenhagen-based Acesion Pharma have launched a collaboration to apply AI-enhanced formulation development to Acesion's early-stage pipeline of small molecules targeting atrial fibrillation, a condition affecting an estimated 50-60 million people globally.

AI tool uses Bayesian optimization to screen drug formulations for clinical success

The collaboration deploys Quotient Sciences' new AI-enhanced formulation development solution within its Translational Pharmaceutics platform, applying active machine learning with Bayesian optimization to identify and prioritize drug products most likely to succeed in clinical testing. The approach is designed to compress early clinical decision-making timelines for sponsors developing new treatments.

Bank Merger, Telecom JV and Food M&A Headline Corporate Dealmaking

New York – October 02, 2026 -- Corporate dealmaking accelerated this week as Peoples Bancorp Inc. and Capital Bancorp, Inc. agreed to merge into a $14 billion-asset bank, and AT&T, T-Mobile and Verizon launched a joint venture aimed at eliminating mobile dead zones, underscoring consolidation pressure across financial services and telecommunications infrastructure.

Peoples Bancorp and Capital Bancorp combine into a $14 billion-asset institution

The merger agreement between Peoples Bancorp Inc. and Capital Bancorp, Inc. will create a combined entity with approximately $14 billion in total assets, $10 billion in total loans and $11 billion in total deposits. The new bank will operate more than 150 banking locations across eight states and Washington, D.C., alongside nationwide specialty financial services platforms.

CIP Commits EUR 270M to 350MW Scottish Battery Storage Project

Kilmarnock – October 02, 2026 -- Copenhagen Infrastructure Partners (CIP) has taken a Financial Investment Decision for Kilmarnock South, a 350 MW/1,400 MWh lithium-ion battery energy storage system in south Ayrshire, Scotland, committing over EUR 270 million (GBP 232 million) through its fourth flagship fund, Copenhagen Infrastructure IV.

Construction begins with commercial operations targeted for Q1 2028

Kilmarnock South is now under construction and is scheduled to reach commercial operations in the first quarter of 2028. At four hours of duration, it will become the longest-duration asset in CIP's UK storage portfolio once operational, designed to store surplus Scottish wind power and release it to the grid during periods of network capacity.

HOP Events to Expand to 25 Cities, 250 Shows Annually by 2028

Dubai – October 02, 2026 -- HOP Events, the cultural entertainment platform under Dubai-based PANTHEON ACR, has announced plans to expand into 25 cities over the next 24 months, delivering more than 250 experiences annually across 75 venues and arenas to over one million attendees each year.

Expansion targets major global hubs including Dubai, London, New York, Doha and Singapore

Chairman Kalpesh Kinariwala confirmed the rollout will span 25 cities worldwide, positioning HOP Events as a regional cultural platform moving beyond standalone live entertainment into a broader community-focused ecosystem. The company frames the expansion not as a growth-for-growth's-sake strategy but as an effort to build shared cultural experiences across diverse global audiences.

Tianjin University's BCI Device Cuts Diagnosis Time to 30 Minutes

Tianjin, China – October 02, 2026 -- Tianjin University's "Shengong-Shengao" system has become China's first approved brain-computer interface (BCI) medical device for diagnosing cognitive impairment, cutting diagnosis time for conditions like hydrocephalus from days to just 30 minutes. The milestone marks a commercial breakthrough as TJU, China's first modern university, marks its 131st anniversary on October 2, 2026.

Shengong device line moves from lab to clinical wards nationwide

Developed by a team led by Professor Liu Xiuyun, the Shengong-Shengao system received regulatory approval and has already been joined by more than 20 additional devices in the Shengong series now deployed in clinical settings. The university states the devices have delivered measurable benefits to thousands of patients, signaling rapid translation of university research into deployable medical hardware.

Subscribe to News